EFTA01120625Set 9
35p11,377w
THIS SECURITY AGREEMENT dated as of June , 2015 (the "Agreement") is by and among
Intellicell Biosciences, Inc., a Nevada corporation (the "Parent"), Intellicell Biosciences, Inc., a New York
corporation (` Intellicell ... Telephone:
Facsimile:
With a copy to:
Telephone:
Facsimile:
And if to any Grantor: c/o Intellicell Biosciences, Inc.
460 Park Avenue, 17th Floor
New York, NY 10022
Attention: Steven Victor ... hereto have executed this Security Agreement as of the date first
above written.
GRANTORS
INTELLICELL BIOSCIENCES, INC., a Nevada corporation
By:
Name:
Title:
INTELLICELL BIOSCIENCES, INC., a New York corporation
https://www.justice.gov/epstein/files/DataSet%209/EFTA01120625.pdf
EFTA00633529Set 9
2012-11-083p863w
thank the team, lawyers, consultants and shareholders for all their support and hard work
IntelliCell BioSciences Announces FDA Listing For Human
Cells, Tissues, and Cellular Based Products
NEW YORK, November ... IntelliCell BioSciences, Inc. ("Company") (SVFC) announced today that it has been
notified according to the FDA validation registration number 3009842420, that its new facility located at 460 Park
Avenue ... look forward to working with FDA to meet any and all
requirements."
About IntelliCell BioSciences
IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the
regenerative, curative
https://www.justice.gov/epstein/files/DataSet%209/EFTA00633529.pdf
EFTA01931157Set 10
2014-03-124p750w
maitcom •
rom: teven ictor
Sent: Wed 3/12/2014 7:17:06 PM
Subject: Dr Andrews
IntelliCell BioSciences Joins Forces With Dr.
James Andrews's Research and Educational
Foundation
Press Release ... SVFC 0.009 +0.002
EFTA_R1_00382179
EFTA01931158
NEW YORK, NY—(Marketwired - Mar tz, 2014) - IntelliCell Biosciences, Inc.
("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company
utilizing adult autologous ... continue our effort towards excellence in clinical stem cell therapy
research."
About IntelliCell Biosciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative
medical markets using adult
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01931157.pdf
EFTA00684414Set 9
2014-01-303p721w
Court for Intellicell
Date: Thu, 30 Jan 2014 12:56:18 +0000
IntelliCell BioSciences Announces Favorable Ruling
Against Ironridge Global IV, LTD., and TCA Global Credit
Masterfund, LP
isitAarketwired Press ... Email Print
RELATED QUOTES NEW YORK, NY--(Marketwired - Jan 29, 2014) - IntelliCell
Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a
Change regenerative medicine company utilizing adult autologous vascular
SVFC ... view that the decision puts all of those claims
to bed."
About IntelliCell Biosciences
EFTA00684414
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative
medical markets using
https://www.justice.gov/epstein/files/DataSet%209/EFTA00684414.pdf
EFTA01955010Set 10
2013-10-104p736w
Victor MD
Sent: Thur 10/10/2013 8:32:55 PM
Subject: MD GLOBAL PARTNERS ADVISORS
IntelliCell Biosciences Engages MD Global
Partners, LLC as Advisor to the Company
Press Release: Intl ... QUOTES
Symbol Price Change
SVFC 0.0106 -0.0018
NEW YORK, NY--(Marketwired - Oct to, 2013) - IntelliCell Biosciences, Inc. (OTCQB: SVFC), a
regenerative medicine company utilizing adult autologous vascular fraction cells (SVFCs ... companies, similar to IntelliCell achieve
their goals."
Dr. Steven Victor, Chairman and CEO of IntelliCell Biosciences, commented, "IntelliCell believes that
we possess a paradigm shifting discovery that will change
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01955010.pdf
EFTA01951603Set 10
2013-10-094p872w
10/9/2013 1:32:20 PM
Subject Press Release Diabetes and Bell's Palsy
IntelliCell Biosciences Stem Cells Used to
Successfully Treat Bell's Palsy and Type I
Diabetes Patient
Press ... QUOTES
Symbol Price Change
SVFC 0.011 0.000
NEW YORK, NY--(Marketwired - Oct 9, 2013) - IntelliCell Biosciences, Inc. (OTCQB: SVFC), a
regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived ... daily to 5-10 Units
ofInsulin daily.
Dr. Steven Victor, Chairman and CEO of IntelliCell Biosciences, commented, "This was a clinical
treatment utilizing IntelliCell's SVFC method, which addressed
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01951603.pdf
EFTA00419545Set 9
2012-02-171p113w
From:
To: Steven Victor MD
Subject: Re: Intellicell BioScience
Date: Fri, 17 Feb 2012 13:06:40 +0000
Ok. Thanks.
Sent from my iPhone ... jeevacation <jeevacation@gmail.com>• >; rkahn <
Sent: Fri, Feb 17, 2012 7:59 am
Subject: Intellicell BioScience
Want to invest SVFC Intellicell BioSciences PPM priced at $1 per share with 2 warrants ... approx $1.9 M done
Thought you might want to invest?
Steven Victor MD
IntelliCell BioSciences
Chairman/CEO
New York, New York 10021
Fax
Cell
www.IntelliCellBioSciences.corn
EFTA00419545
https://www.justice.gov/epstein/files/DataSet%209/EFTA00419545.pdf
EFTA02038330Set 10
2011-06-0311p648w
SCHEDULES
to the
SECURITIES PURCHASE AGREEMENT
by and among
Intellicell Biosciences, Inc.
and
the Purchasers signatory thereto
Dated: September 2011
EFTA_R1_00552331
EFTA02038330
These Schedules are pursuant to that ... Securities Purchase Agreement dated
as of September 2011 (the "Agreement") by and between the Intellicell Biosciences,
Inc. and the Purchasers signatory thereto. Capitalized terms used herein but not otherwise
defined ... other standard for disclosure under
the Agreement. No representations and warranties are made by Intellicell Biosciences,
Inc. other than as and to the extent expressly set forth in the Agreement
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02038330.pdf
EFTA01120583Set 9
42p13,508w
THIS SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of
June 2015, by and between INTELLICELL BIOSCIENCES, INC., a Nevada
corporation (the "Company"), and , a (the
"Buyer").
WITNESSETH
WHEREAS, subject ... such
23
MI481914 v4
EFTA01120605
communications shall be:
If to the Company, to: Intellicell Biosciences, Inc.
460 Park Avenue, 17th Floor
New York, NY 10022
Attention: Steven Victor, MD
Telephone ... Purchase Agreement to be duly executed as of
the date first written above.
COMPANY:
INTELLICELL BIOSCIENCES, INC.
By:
Name: Steven Victor, MD
Title: Chairman
27
P41-481914 v4
EFTA01120609
https://www.justice.gov/epstein/files/DataSet%209/EFTA01120583.pdf
EFTA02038361Set 10
15p6,152w
FIDE MARGIN ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES.
COMMON STOCK PURCHASE WARRANT
INTELLICELL BIOSCIENCES, INC.
Warrant Shares: Initial Exercise Date: , 2011
THIS COMMON STOCK PURCHASE WARRANT (the "Warrant ... Exercise Date (the "Termination Date") but not thereafter, to
subscribe for and purchase from Intellicell Biosciences, Inc., a Nevada corporation (the
"Company") up to shares (as subject to adjustment hereunder ... executed
by its officer thereunto duly authorized as of the date first above indicated.
INTELLICELL BIOSCIENCES, INC.
By:
Name:
Title:
13
EFTA_R1_00552374
EFTA02038373
NOTICE OF EXERCISE
TO: INTELLICELL
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02038361.pdf
EFTA02038341Set 10
20p7,655w
parties have executed this Registration Rights
Agreement as of the date first written above.
INTELLICELL BIOSCIENCES, INC.
By:
Name:
Title:
[SIGNATURE PAGE OF HOLDERS FOLLOWS]
EFTA_R1_00552356
EFTA02038355
[SIGNATURE ... PAGE OF HOLDERS TO INTELLICELL BIOSCIENCES RRA]
Name of Holder:
Signature ofAuthorized Signatory ofHolder:
Name of Authorized Signatory:
Title of Authorized Signatory:
16
EFTA_R1_00552357
EFTA02038356
Annex A
Intellicell ... beneficial owner of common stock, par value $.01 per share (the
"Common Stock"), of Intellicell Biosciences, Inc., a Nevada corporation (the "Company"),
understands that the Company has filed or intends
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02038341.pdf
EFTA00968198Set 9
2013-08-213p632w
Attachments: ICBS_Hospitals_June_20.ppt
Here is what we do
Steven Victor MD
Chairman
Intellicell Biosciences Inc
460 Park Avenue 17th Floor
New York, NY 10022
212-249-3050 Regen Medical PC
Cell ... then it will work so need to meet the Governor
Steven Victor MD
Chairman
Intellicell Biosciences Inc
460 Park Avenue 17th Floor
New York, NY 10022
212-249-3050 Regen ... better technology
Let me know I will send you info
Steven Victor MD
Chairman
Intellicell Biosciences Inc
460 Park Avenue 17th Floor
New York, NY 10022
212-249-3050 Regen
https://www.justice.gov/epstein/files/DataSet%209/EFTA00968198.pdf
EFTA00676256Set 9
2015-11-151p190w
Date: Sun, 15 Nov 2015 22:52:53 +0000
Steven Victor MD
CEO
ReGenMedicalPC
Intellicell Biosciences
460 Park Ave 17th floor
New York New York 10022
Www.RegenMedicalPC.com
Www.Intellicellbiosciences.com
CONFIDENTIALITY NOTICE ... This message (including any attachments) is intended solely for the use of INTELLICELL
BIOSCIENCES, INC.. its affiliates and the individual addressee(s). This message may contain confidential and/or private ... part by persons or entities other than the intended recipient is strictly prohibited. INTELLICELL
BIOSCIENCES, INC. shall not be liable for the improper or incomplete transmission of the information contained
https://www.justice.gov/epstein/files/DataSet%209/EFTA00676256.pdf
EFTA00964821Set 9
2013-07-084p548w
Attachments: Cell_Therapy_Industry_7.8.13.pdf; image001.png
Steven Victor MD
IntelliCell BioSciences
Chairman/CEO
Original Message—
From: Steven Victor
To: admin
Sent: Mon, Jul 8, 2013 8:10 am
Subject: FW: Maxim Group: Regenerative Cell ... clinical,
manufacturing, and clinical data that drive safety
Steven Victor MD
Chairman
Intellicell Biosciences Inc
From: admin SS>
Date: Monday, July 8, 2013 8:05 AM
To: admin
Subject ... clinical,
manufacturing, and clinical data that drive safety
Steven Victor MD
Chairman
Intellicell Biosciences Inc
EFTA00964821
From: Jason Kolbert <jasonkolbert&ptonline.net>
Date: Monday, July
https://www.justice.gov/epstein/files/DataSet%209/EFTA00964821.pdf
EFTA02038377Set 10
18p7,757w
INTELLICELL BIOSCIENCES, INC.
CERTIFICATE OF DESIGNATION OF PREFERENCES,
RIGHTS AND LIMITATIONS
OF
SERIES D CONVERTIBLE PREFERRED STOCK
PURSUANT TO SECTION 78.1955
OF THE NEVADA REVISED STATUTES
The undersigned, Steven ... does hereby certify that:
1. He is the Chief Executive Officer and President of Intellicell Biosciences, Inc., a
Nevada corporation (the "Corporation").
2. The Corporation is authorized to issue ... into shares of common stock, par value $0.01 per share (the "Common
Stock"), of Intellicell Biosciences, Inc., a Nevada corporation (the "Corporation") according to
the conditions hereof
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02038377.pdf